Trump raises more money from women than all his Democratic

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
157
Trump raises more money from women than all his Democratic women challengers ... put together
By Monica Showalter

As Democrats cobble on about their chances of beating President Trump, and backslap with one another about how 'beatable' the man is, here's some news to give them indigestion from Lauren DeBellis Appell at Real Clear Politics:

The Center for Responsive Politics, which uses Federal Election Commission data, found that during the first three months of 2019 the number of women who donated to President Trump’s 2020 reelection campaign topped the number of women who donated to any Democratic candidate running for president, accounting for more than 45 percent of all individual donations.

That means President Trump had more female donors than Kamala Harris, more than Elizabeth Warren, more than Amy Klobuchar, more than Kirsten Gillibrand, and more than Tulsi Gabbard. In fact, wrap your head around this: More women donated to President Trump than to all of the female candidates combined.

So all that packaging, all that flavor of the month among the Democratic elites' choices of women to represent all women - Kamala Harris, Liz Warren, Amy Klobuchar, the sexism-whining Kirsten Gillebrand, Tulsi Gabbard and outliers such as Marianne Williamson - all these women who were put out there to appeal to women - was for nothing.

Message: Vote for me, I'm a woman - is not playing with women voters.

Here's some news for these Democratic fans of 'year of the woman,' 'war on women,' and other drecky slogans supposedly to manipulate women. Women are impressed with Trump's performance. The 'pussy-grabbing' illicit tape recordings, the brash manner, the tweets, the orange hair - are meaningless in the face of what really matters, which is Trump's record.

What's more, Democrats are not offering much in their smorgasbord of many-colored, many-aged women candidates. They're all offering the same socialism. Women socialists are as bad as man socialists, because socialism fails every time you try it -- and even if a woman is trying it. The female-ness of the Democrat candidate slage, put out there to appeal to a group identity, is simply a dud when you consider how bad these people's proposals are.

Seriously, Liz Warren's free college? How much do taxes get to go up for that coming mess? Or how about 'no health insurance, let the government make your health care choices for you, trust us, we'll do it good' Kamala Harris? Destroy ICE, but maybe don't destroy ICE and let's whine about men Kirsten Gillebrand? Defend Maduro and all the things he's done for women Tulsi Gabbard? Comb-eating, staff-terror Amy Klobuchar? Out there Marianne Williamson?

Who'd want to vote for any of these people?

By contrast, President Trump has created the best job market for women in decades, complete with rising salaries. He's stood up for Angel Moms, whose children have been murdered by illegal immigrants. The people he pardons tend to be military men in military families, heartening many military wives.

As far as female representation, if that's important to some people, well, there are examples of it. On the personal front, he has an admirable wife. He's the father of an impressive businesswoman daughter and an equally accomplished law-student daughter. And we haven't heard a thing about sexism or misery for women working in the White House. If being a female is important to some voters, well, there are many strong women in key positions in his administration, starting with his much-admired spokeswoman Sarah Sanders and his close advisor Kellyanne Conway. The CIA chief is a woman, the education secretary is a woman, his first UN ambassador was a woman, and Trump's last Homeland Security chief exited amiably after doing a good job, also a woman. Many more, but I have not looked closely, because frankly, it's irrelevant.

I'm not alone. None of this matters to most women as this money poll shows - Trump's cabinet could all be Martians if they could turn out the same job as the current Trump team. Results say something, results matter, and Trump has produced results. It's not about pronoun, it's about the performance. Trump has produced the latter and women are responding.

Yet Democrats have thrown a lot of their eggs in one basket as they have sought to promote identity politics to sweeten the socialism pill.

It's not working. Women are putting their money down in droves for Trump because performance, not appearance, is what matters.

Read more: https://www.americanthinker.com/blog/2019/05/...z5oDgndZcH
Follow us: @AmericanThinker on Twitter | AmericanThinker on Facebook
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 21

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 33

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 344

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 239

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 169

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading